Bruno Julianne
Galecto, Inc. · Director
Bruno Julianne is listed in filings as Director at Galecto, Inc.. This profile follows SEC Form 4 activity through Mar 25, 2026, including sale activity. Recent filings connect the profile to Galecto, Inc. (GLTO), Damora Therapeutics, Inc. (DMRA), and CRISPR Therapeutics AG-Common Shares (CRSP). The current snapshot covers public activity from Jun 24, 2024 to Mar 25, 2026. Reported amounts are shown as $860.1K to $898.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $189k3.4k shares | SellJun 21, 2024 | $56.09 | $47.58 | |
| $18k333 shares | SellFeb 19, 2025 | $52.80 | $47.58 | |
| $51k1.2k shares | SellMar 11, 2025 | $42.42 | $47.58 | |
| $8.2k190 shares | SellMar 12, 2025 | $43.32 | $47.58 |